Influence of Brugia malayi life stages and BmAFII fraction on experimental Leishmania donovani infection in hamsters.
The influence of live Brugia malayi parasites and a Sephadex G-200 fraction of the adult parasite extract (BmAFII) on the progression of Leishmania donovani infection was studied. Inbred hamsters were first infected with B. malayi infective 3rd stage larvae (L3), adult worms or microfilariae (mf), and then with L. donovani amastigotes (Ld), or vice versa or received both the infections simultaneously; a group of animals were first immunized with BmAFII and then infected with Ld. L. donovani parasite burden was determined between 17 and 19 days post amastigote challenge (p.a.c.) and, in case of immunized animals, between 32 and 35 days p.a.c also. Nitric oxide (NO) release from peritoneal macrophages and cellular proliferative responses of lymphnode cells were assessed in BmAFII-immunized animals given leishmania infection or no infection. Leishmanial parasite burden was significantly reduced in animals exposed to filarial L3 before amastigote inoculation and in animals given filarial adult worms after or together with amastigotes. Prior immunization of leishmania-infected animals with BmAFII also reduced the leishmanial parasite burden (17-19 days p.a.c.: >90%; 32-35 days p.a.c.: 60%). These animals showed upregulation of NO release and cellular proliferative responses to promastigote antigen or BmAFII stimulation in vitro. The findings show, for the first time, that B. malayi L3/adult worms or immunization with BmAFII inhibits progression of L. donovani infection in hamsters and this is associated with upregulation of NO and lymphocyte proliferative responses indicating that Th1 response might be responsible for this.
Murthy
P K
PK
Division of Parasitology, Central Drug Research Institute, Lucknow 226001, India. drpkmurthy@yahoo.com
Dixit
S
S
Gaur
R L
RL
Kumar
Ramesh
R
Sahoo
M K
MK
Shakya
Nishi
N
Joseph
S K
SK
Palne
Shradha
S
Gupta
Suman
S
D000818:Animals; D000947:Antigens, Helminth / Q000008:administration & dosage / Q000276:immunology* / Q000302:isolation & purification; D017178:Brugia malayi / Q000276:immunology*; D049109:Cell Proliferation; D006224:Cricetinae; D005368:Filariasis / Q000276:immunology* / Q000469:parasitology; D007893:Leishmania donovani / Q000254:growth & development* / Q000302:isolation & purification*; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000276:immunology* / Q000469:parasitology; D008198:Lymph Nodes / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D017737:Macrophages, Peritoneal / Q000276:immunology; D008297:Male; D009569:Nitric Oxide / Q000096:biosynthesis
D000947:Antigens, Helminth; D009569:Nitric Oxide